Effect of Preoperative Aspirin in Patients Undergoing Off-pump Coronary Artery Bypass Grafting

Effect of Preoperative Aspirin in Patients Undergoing Off-pump Coronary Artery Bypass Grafting: A Double-blind, Placebo-controlled, Randomized Trial

Effect of Preoperative Aspirin in patients undergoing Off-pump Coronary Artery Bypass Grafting. A double-blind, placebo-controlled, randomized trial.

Inclusion Criteria:

• Eligible patients undergoing off-pump coronary artery bypass grafting (OPCAB)
• Patients in whom antiplatelet therapy was stopped 5-7 days prior to OPCAB

Exclusion Criteria:

• Patients undergoing on-pump coronary artery bypass grafting
• Patients in whom antiplatelet therapy was not stopped 5-7 days prior to OPCAB
• Intraoperative conversion to on-pump coronary artery bypass grafting
• Patients with inherited blood-clotting disorders
• Patients undergoing other cardiac operations